 | 8-OH-Dpat | IC50 | 0.59 [1], 0.66 [2] |
| 8-OH-Dpat | Ki | 0.4 [1] |
 | Serotonin | IC50 | 1.2 [1], 2.0 [2], 5.6 [3], 6.0 [4] |
| Serotonin | Ki | 2.48 [1], 2.8 [2], 3.0 [3] |
 | Buspirone | IC50 | 25.0 [1] |
 | Clozapine | IC50 | 150.0 [1] |
| Clozapine | Ki | 140.0 [1] |
 | Cyclohexanecarboxamide, n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-n-2-pyridinyl- | IC50 | 7.1 [1], 11.3 [2] |
| Cyclohexanecarboxamide, n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-n-2-pyridinyl- | Ki | 0.5 [1], 0.59 [2], 2.2 [3] |
 | 8-(2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl)-8-azaspiro[4.5]decane-7,9-dione | Ki | 1.26 [1] |
 | Sumatriptan | IC50 | 398.11 [1], 501.19 [2] |
| Sumatriptan | Ki | 440.0 [1] |
 | WAY-100635 hydrochloride | IC50 | 4.04 [1], 7.06 [2], 7.1 [3], 8.4 [4], 37.0 [5] |
| WAY-100635 hydrochloride | Ki | 0.6 [1] |
 | Olanzapine | Ki | 2720.0 [1] |
 | Haloperidol | IC50 | 1500.0 [1] |
| Haloperidol | Ki | 1703.0 [1], 2800.0 [2], 3600.0 [3] |
 | Quetiapine | Ki | 79.43 [1], 125.0 [2], 230.0 [3], 830.0 [4], 1000.0 [5] |
 | Ziprasidone | Ki | 1.58 [1], 2.0 [2], 2.5 [3], 4.0 [4], 37.0 [5] |
 | (2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane | Ki | 2.09 [1] |
 | 6-[2-[4-(2-Methylquinolin-5-yl)piperazin-1-yl]ethyl]-4H-1,4-benzoxazin-3-one | Ki | 0.06 [1], 0.25 [2] |
 | 3-Propyl-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]indol-9-ol | Ki | 0.1 [1], 0.2 [2], 3.0 [3] |
 | [2-(6-Fluoro-chroman-8-yloxy)-ethyl]-[3-(5-fluoro-1H-indol-3-yl)-propyl]-amine | IC50 | 49.0 [1], 121.0 [2] |
| [2-(6-Fluoro-chroman-8-yloxy)-ethyl]-[3-(5-fluoro-1H-indol-3-yl)-propyl]-amine | Ki | 26.6 [1], 27.0 [2] |
 | Apomorphine | Ki | 296.0 [1], 534.0 [2] |
 | Prazosin | Ki | 10.0 [1], 1000.0 [2], 1800.0 [3] |
 | Pindolol | Ki | 22.4 [1], 24.0 [2], 81.1 [3], 110.0 [4] |
 | Rizatriptan | IC50 | 316.23 [1], 398.11 [2] |
| Rizatriptan | Ki | 140.0 [1], 293.0 [2] |
 | 2-Naphthalenecarboxamide, N-(4-(4-(2-methoxyphenyl)-1-piperazinyl)butyl)- | Ki | 81.0 [1], 174.0 [2] |
 | N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]-1-benzothiophene-2-carboxamide | Ki | 198.0 [1], 360.0 [2] |
 | N-[2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylcyclohexanecarboxamide;hydrochloride | IC50 | 2.1 [1], 4.9 [2] |
| N-[2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylcyclohexanecarboxamide;hydrochloride | Ki | 0.25 [1], 0.33 [2] |
 | 3-{Cyclobutyl[3-(5-fluoro-1H-indol-3-yl)propyl]amino}-8-fluorochromane-5-carboxamide | IC50 | 61.0 [1], 202.0 [2] |
| 3-{Cyclobutyl[3-(5-fluoro-1H-indol-3-yl)propyl]amino}-8-fluorochromane-5-carboxamide | Ki | 9.3 [1] |
 | 5-Fluoro-3-{4-[4-(1H-indol-4-yl)-piperazin-1-yl]-cyclohexyl}-1H-indole | Ki | 4.62 [1], 36.7 [2] |
 | CID 11845636 | IC50 | 23.0 [1], 488.0 [2] |
| CID 11845636 | Ki | 2.14 [1] |
 | (3R)-3-[Cyclobutyl-[3-(5-fluoro-1H-indol-3-yl)propyl]amino]-8-fluoro-3,4-dihydro-2H-chromene-5-carboxamide | IC50 | 27.0 [1], 48.0 [2] |
| (3R)-3-[Cyclobutyl-[3-(5-fluoro-1H-indol-3-yl)propyl]amino]-8-fluoro-3,4-dihydro-2H-chromene-5-carboxamide | Ki | 1.2 [1] |
 | (3S)-(+)-3-{Cyclobutyl[3-(5-fluoro-1H-indol-3-yl)propyl]amino}-8-fluorochromane-5-carboxamide | IC50 | 926.0 [1], 1000.0 [2] |
| (3S)-(+)-3-{Cyclobutyl[3-(5-fluoro-1H-indol-3-yl)propyl]amino}-8-fluorochromane-5-carboxamide | Ki | 253.0 [1] |
 | 1-(2-(3-Iodo-4-aminophenyl)ethyl)-4-(3-(trifluoromethyl)phenyl)piperazine | IC50 | 38.0 [1], 40.0 [2] |
| 1-(2-(3-Iodo-4-aminophenyl)ethyl)-4-(3-(trifluoromethyl)phenyl)piperazine | Ki | 19.0 [1], 20.0 [2] |
 | 1-(2-(3-Iodo-4-azidophenyl)ethyl)-4-(3-(trifluoromethyl)phenyl)piperazine | IC50 | 35.0 [1], 40.5 [2] |
| 1-(2-(3-Iodo-4-azidophenyl)ethyl)-4-(3-(trifluoromethyl)phenyl)piperazine | Ki | 17.5 [1], 20.3 [2] |
 | (3S)-2-[6-[4-(2-Methylsulfanylphenyl)piperazin-1-yl]hexanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxamide | Ki | 1.0 [1], 19.0 [2], 98.0 [3] |
 | 3-{1-[2-(1H-Indol-4-yloxy)-ethyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1H-pyrrolo[2,3-b]pyridine | IC50 | 12.0 [1], 38.9 [2] |
| 3-{1-[2-(1H-Indol-4-yloxy)-ethyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1H-pyrrolo[2,3-b]pyridine | Ki | 10.9 [1] |
 | 3-{2-[4-(3-Trifluoromethyl-phenyl)-piperazin-1-yl]-ethyl}-phenylamine | IC50 | 8.1 [1], 10.0 [2] |
| 3-{2-[4-(3-Trifluoromethyl-phenyl)-piperazin-1-yl]-ethyl}-phenylamine | Ki | 4.0 [1], 5.0 [2] |
 | 1-[2-(3-Azido-phenyl)-ethyl]-4-(3-trifluoromethyl-phenyl)-piperazine | IC50 | 3.1 [1], 5.0 [2] |
| 1-[2-(3-Azido-phenyl)-ethyl]-4-(3-trifluoromethyl-phenyl)-piperazine | Ki | 1.5 [1], 2.5 [2] |
 | Lysergide | Ki | 1.1 [1], 1.26 [2] |
 | Mianserin | IC50 | 398.11 [1] |
| Mianserin | Ki | 500.0 [1] |
 | Quipazine | IC50 | 1445.44 [1] |
| Quipazine | Ki | 230.0 [1] |
 | 5-Carboxamidotryptamine | IC50 | 0.3 [1] |
| 5-Carboxamidotryptamine | Ki | 0.3 [1], 0.63 [2] |
 | Methiothepin | Ki | 2.2 [1], 4.0 [2], 4.6 [3] |
 | GR-127935 | Ki | 70.0 [1], 72.0 [2], 80.0 [3] |
 | Gepirone | IC50 | 114.0 [1] |
| Gepirone | Ki | 13.0 [1], 31.8 [2] |
 | 4-Fluoro-N-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]benzamide | Ki | 22.0 [1], 22.1 [2] |
 | Lecozotan | IC50 | 25.0 [1], 42.0 [2] |
| Lecozotan | Ki | 1.6 [1] |
 | 6-[4-(2-Methylsulfanylphenyl)piperazin-1-yl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)hexanamide | Ki | 52.7 [1] |
 | 3-Amino-2-[4-(4-quinolin-2-ylpiperazin-1-yl)butyl]-5,6,7,8-tetrahydroquinazolin-4-one | IC50 | 1.36 [1], 1.4 [2] |
| 3-Amino-2-[4-(4-quinolin-2-ylpiperazin-1-yl)butyl]-5,6,7,8-tetrahydroquinazolin-4-one | Ki | 0.7 [1] |
 | 4-[3-(4-Chlorophenyl)-3-hydroxy-8-azabicyclo[3.2.1]oct-8-yl]-1-(4-fluorophenyl)butan-1-one | Ki | 27.7 [1] |
 | (3Ar,9bS)-3-Allyl-6-methoxy-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]indole | Ki | 236.0 [1], 333.0 [2] |
 | (3Ar,9bS)-3-Allyl-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]indol-6-ol | Ki | 54.0 [1], 923.0 [2], 1000.0 [3] |
 | 1-Allyl-2,3,3a,4,9,9a-hexahydro-1H-benzo[f]indol-5-ol | Ki | 56.0 [1], 470.0 [2] |
 | (3As,9aR)-1-Allyl-5-methoxy-2,3,3a,4,9,9a-hexahydro-1H-benzo[f]indole | Ki | 41.0 [1] |
 | 1-Propyl-2,3,3a,4,9,9a-hexahydro-1H-benzo[f]indol-5-ol | Ki | 36.0 [1] |
 | (3Ar,9bS)-3-Allyl-9-methoxy-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]indole | Ki | 0.8 [1], 1.2 [2], 49.0 [3] |
 | 9-Methoxy-3-propyl-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]indole | Ki | 0.2 [1], 186.0 [2] |
 | N-[2-(2,6-Dimethoxyphenoxy)ethyl]-2-(2-phenylmethoxyphenoxy)ethanamine | Ki | 0.07 [1], 11.75 [2] |
 | 5-Methoxy-1-propyl-2,3,3a,4,9,9a-hexahydro-1H-benzo[f]indole | Ki | 17.0 [1], 37.0 [2], 38.0 [3] |
 | 1-[4-(3,4-Dihydro-1H-isoquinolin-2-yl)butyl]-3H-indol-2-one | Ki | 219.0 [1] |
 | N,N-Dimethyl-1-(3-oxa-2-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7,9,11,14,16-hexaen-4-yl)methanamine | IC50 | 977.24 [1] |
 | (2S,3As,9aS)-8-Methoxy-2-methyl-1-propyl-2,3,3a,4,9,9a-hexahydro-1H-benzo[f]indole | Ki | 11.0 [1] |
 | 8-Methoxy-2-methyl-1-propyl-2,3,3a,4,9,9a-hexahydro-1H-benzo[f]indole | Ki | 384.0 [1] |
 | (3As,9aS)-1-Allyl-8-methoxy-2,3,3a,4,9,9a-hexahydro-1H-benzo[f]indole | Ki | 145.0 [1] |
 | Rac-[3-(5-fluoro-1H-indol-3-yl)-propyl]-(5-methoxy-chroman-3-yl)-propyl-amine | Ki | 15.8 [1] |
 | (3Ar,9bS)-3-Allyl-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]indol-9-ol | Ki | 0.3 [1] |
 | N-(3-(1-(2-(2-Methylquinolin-5-yloxy)ethyl)piperidin-4-ylmethyl)phenyl)methanesulfonamide | Ki | 2.51 [1] |
 | 2-(2,6-Dimethoxyphenoxy)-N-[[(2R)-6,6-diphenyl-1,4-dioxan-2-yl]methyl]ethanamine | Ki | 1.41 [1], 44.67 [2] |
 | N-[[(2R)-6,6-Diphenyl-1,4-dioxan-2-yl]methyl]-2-(2-methoxyphenoxy)ethanamine | Ki | 0.6 [1], 0.66 [2] |
 | N-[[(2R)-6,6-Diphenyl-1,4-dioxan-2-yl]methyl]-2-phenoxyethanamine | Ki | 0.59 [1], 1.48 [2] |
 | 8-[2-[4-(2-Methylquinolin-5-yl)piperazin-1-yl]ethyl]-4H-1,4-benzoxazin-3-one | Ki | 0.25 [1] |
 | 4-Methyl-8-[2-[4-(2-methylquinolin-5-yl)piperazin-1-yl]ethyl]-1,4-benzoxazin-3-one | Ki | 0.16 [1] |
 | (2S)-1-[(2S,4R)-4-(1-Benzothiophen-2-yl)-2-methylpiperidin-1-yl]-3-[(2-methyl-1H-indol-4-yl)oxy]propan-2-ol | Ki | 7.11 [1] |
Calculator
